Choline
Choline is a nutrient your body needs every day. The richest UK food sources are eggs (about 150 mg per large egg) and liver; salmon, chicken, milk, broccoli, and soy lecithin contribute smaller amounts. Most UK adults who regularly eat eggs roughly hit the daily target from food alone (around 400 mg/day for adults, rising to 480 mg/day in pregnancy and 520 mg/day during breastfeeding). National diet surveys show many adults — vegans, dairy-avoiders, and people who never eat eggs in particular — fall short. Pregnancy is the most important life stage to think about choline. A controlled feeding trial reported that babies whose mothers consumed more choline in the third trimester scored better on sustained-attention tests at age seven. The current NHS pregnancy supplement bundle (folic acid + vitamin D + iodine) does NOT yet include choline routinely — so if you're pregnant or trying to conceive, talk to your midwife or GP before adding it, particularly if you don't eat eggs. Three UK Article 13.1 health claims are authorised for choline: normal lipid metabolism, normal homocysteine metabolism, and maintenance of normal liver function. No memory or "smart drug" claim is authorised — the cognitive-marketing forms (alpha-GPC, citicoline) have small early-trial evidence in specific clinical populations, not in healthy adults seeking a focus boost. Camden does NOT stock a single-active choline supplement — for most people the practical option is dietary (eggs, salmon, soy lecithin) or, in pregnancy, a multivitamin that already includes choline alongside the NHS bundle.
Camden Medicals editorial · Last reviewed 12 June 2026 · Next review June 2027
- Cross-checked against
- NHS
- NICE
- BNF
- EFSA
- FSA
Camden's editorial team independently graded each health claim below on the strength of the published evidence — see the grade beside every condition.
- Class
- Other
- Typical daily dose
- General dietary supplementation: 100-300 mg/day choline as choline bitartrate or phosphatidylcholine. Pregnancy supplementation: 200-450 mg/day, often as phosphatidylcholine. Cognitive-marketed alpha-GPC: 300-1000 mg/day. CDP-choline: 250-1000 mg/day.
- Top use evidence
- Strong
On this page
What it is
Choline is a nutrient — distinct from but biologically related to the B vitamins — that your body uses to build cell membranes, to make a key brain messenger called acetylcholine, and to help process homocysteine (one of the substances doctors watch when looking at cardiovascular risk). Your liver can make a small amount on its own, but not enough to cover daily needs without food, which is why nutritional bodies classify it as an essential nutrient.
The US Institute of Medicine formally declared choline an essential nutrient in 1998. EFSA followed in 2016 with a Dietary Reference Value opinion setting an Adequate Intake (AI) — a slightly looser standard than a Reference Nutrient Intake (RNI), used when the evidence supports a sensible daily target but not a precise per-person number. The chemistry name for choline is 2-hydroxy-N,N,N-trimethylethanaminium (a quaternary ammonium compound), but that's a label, not a feature you need to remember.
Choline serves three principal biochemical roles:
Membrane phospholipid synthesis. Phosphatidylcholine accounts for roughly 50% of cell-membrane phospholipid in human tissues. Sphingomyelin (another quaternary-amine phospholipid containing choline) accounts for additional membrane structure, particularly in nervous-system myelin sheaths.
Acetylcholine synthesis. Choline + acetyl-CoA → acetylcholine (the principal cholinergic neurotransmitter for the parasympathetic nervous system and for neuromuscular junction). Acetylcholine signalling is central to memory and attention, the cognitive-marketing axis for alpha-GPC and CDP-choline.
One-carbon methylation pathway. Choline → betaine (via choline dehydrogenase / betaine aldehyde dehydrogenase) → S-adenosyl methionine (via betaine homocysteine methyltransferase, BHMT). Betaine donates a methyl group to homocysteine, regenerating methionine. The pathway is parallel to the folate / B12 / methionine synthase pathway. Adequate choline status reduces homocysteine concentration — the basis for the UK Article 13.1 authorised claim "Choline contributes to normal homocysteine metabolism".
Endogenous synthesis: humans synthesise some choline via PEMT (phosphatidylethanolamine N-methyltransferase), which methylates phosphatidylethanolamine to phosphatidylcholine using S-adenosyl methionine as the methyl donor. PEMT activity is upregulated by oestrogen — premenopausal women have higher PEMT capacity than men or postmenopausal women, partially explaining sex differences in choline requirements. PEMT is encoded by a polymorphic gene (rs7946 SNP); some individuals have reduced PEMT capacity and higher dietary choline requirements.
Dietary sources (UK adult intake patterns):
- Eggs — ~150 mg per large egg (the yolk is the choline-rich part as phosphatidylcholine).
- Beef liver — extremely high (~420 mg per 100 g) but rarely consumed in modern UK diet.
- Salmon, chicken — meaningful contributors.
- Milk and dairy — modest contribution.
- Soy and soy lecithin — significant (lecithin is ~13% phosphatidylcholine by weight; soy is the principal commercial lecithin source).
- Sunflower lecithin — alternative for soy-allergic.
- Broccoli, cauliflower — modest plant-source contribution.
UK adult choline intake from diet typically averages 250-350 mg/day — below the EFSA AI of 400 mg/day in significant fractions of the population (NDNS data). Pregnant women fall further below pregnancy AI (480 mg/day) without specific supplement intake.
Supplement forms:
- Choline bitartrate — ~40% choline by weight; typical 250-500 mg per serving delivering 100-200 mg elemental choline. Cheapest and most common.
- Choline citrate — similar elemental choline content.
- Phosphatidylcholine (lecithin) — ~13% choline by weight; typical 1200-2400 mg lecithin per serving delivering 150-310 mg choline. Better tolerated by some users than bitartrate; soy-derived (read label for sunflower-source if soy-allergic).
- Alpha-GPC (alpha-glycerylphosphorylcholine) — ~40% choline; cognitive-marketing form; typical 300-600 mg per serving delivering 120-240 mg choline. Some cell-biology evidence for crossing blood-brain barrier; small early-trial evidence in cognitive endpoints.
- CDP-Choline (citicoline) — ~18% choline; cognitive-marketing form; typical 250-500 mg per serving delivering 45-90 mg choline. Used as a prescribed neuro-protective preparation in some EU countries (post-stroke, mild cognitive impairment); UK status is food supplement.
At a glance
- Eggs are the most concentrated common food source (~150 mg per large egg). Most UK adults who eat eggs meet the daily target from food; vegans and dairy-avoiders may fall short.
- EFSA Adequate Intake: 400 mg/day for adults, 480 mg/day in pregnancy, 520 mg/day when breastfeeding. The NHS pregnancy supplement bundle does NOT yet include choline — talk to your midwife or GP before adding it.
- Three UK authorised health claims cover normal lipid, homocysteine and liver function; there is no authorised memory or "smart drug" claim. Across the forms (choline bitartrate, phosphatidylcholine / lecithin, alpha-GPC, citicoline) always read the elemental choline per serving, not the total compound weight.
- Pregnancy is the highest-stakes life stage: one small US controlled trial (Bahnfleth 2022, 7-year follow-up of the Caudill 480-vs-930 mg/day RCT) reported better sustained-attention scores at age 7 in children whose mothers took the higher dose in the third trimester. Avoid supplementing if you have the rare genetic disorder trimethylaminuria (TMAU); the wider gut-microbiome TMAO-to-heart link is real but causally unsettled in humans.
What people use it for
Pregnant women, women planning pregnancy
EFSA Adequate Intake in pregnancy is 480 mg/day — above typical UK dietary intake. Choline supports foetal neural-tube and cognitive development; Caudill 2018 RCT showed higher attention test scores at age 7 in children of mothers supplemented at 930 mg/day vs 480 mg/day during pregnancy. UK NHS pregnancy supplement guidance does not currently include choline routinely; specialist preconception practice increasingly does. Talk to your midwife — 200-450 mg/day supplemental choline (often as phosphatidylcholine for tolerability) is a reasonable conversation alongside the established folate / vitamin D / iodine bundle. [2]
Some evidenceModerateAdults with poor egg / dairy / liver intake (vegan, allergic, or low-protein diet)
UK adult intake from diet typically averages 250-350 mg/day, below the EFSA AI of 400 mg/day in significant fractions of the population — particularly people who avoid eggs (the most concentrated common dietary source) and red meat. Soy lecithin (1200-2400 mg) or sunflower lecithin delivers 150-310 mg supplemental choline as phosphatidylcholine; choline bitartrate at 250-500 mg delivers 100-200 mg elemental choline. Talk to your GP if you have a specific dietary concern; meeting AI from food (eggs, salmon, chicken, soy) is generally preferable. [1]
Some evidenceLimitedAdults considering choline for cognitive enhancement (alpha-GPC, CDP-choline)
Alpha-GPC and CDP-choline are marketed for cognitive enhancement based on cell-biology evidence (BBB-crossing) and small early trials in mild cognitive impairment / post-stroke contexts. UK NICE pathway for dementia (NG97) does not include choline supplementation; UK NICE pathway for cognitive impairment is condition-specific (vascular vs Alzheimer's vs MCI). Self-supplementing alpha-GPC or CDP-choline for healthy-adult cognitive enhancement is not the trial-evidenced use; effect sizes are modest where they exist. [4]
Some evidenceLimitedAdults with diagnosed non-alcoholic fatty liver disease (NAFLD)
Choline status modulates VLDL packaging and hepatic lipid export. Some observational data link low choline intake to NAFLD severity; intervention RCTs are smaller and less consistent. UK NICE NG49 NAFLD pathway is weight management, metabolic-syndrome control, and (in advanced disease) hepatology referral. Choline supplementation can be discussed with the GP managing NAFLD as a dietary adjunct, not as a primary treatment. [3]
Some evidenceLimitedAdults with diagnosed trimethylaminuria (TMAU)
AVOID high-dose choline supplementation in trimethylaminuria (TMAU / fish-odour syndrome): choline is a dietary precursor of trimethylamine, so a high intake worsens the fishy-odour symptom. Restricting choline and other trimethylamine precursors is a recognised part of TMAU management. If you have TMAU, speak to your metabolic specialist before taking any choline-containing supplement. [12,13]
Some evidenceStrongAdults considering choline for cardiovascular health
Mixed evidence. The UK Article 13.1 authorised claim is for normal homocysteine and lipid metabolism — nutrient-status-related, not cardiovascular-prevention-related. The TMAO controversy adds a possible adverse signal at high choline intake. The conservative position is to meet AI (400 mg/day) from a balanced diet without overconsumption. UK NICE NG238 cardiovascular pathway does not include choline. [5]
Popular, not provenMixed
How it works
Choline's three biochemical roles map onto its three UK-authorised health claims and its broader mechanism picture:
Liver function — phosphatidylcholine and lipid export. Hepatocytes synthesise very-low-density lipoprotein (VLDL) particles for export of triglycerides and cholesterol from the liver. VLDL particles require phosphatidylcholine as a structural component of the particle envelope; insufficient hepatic choline leads to fatty liver because triglycerides accumulate in hepatocytes when VLDL synthesis is impaired. The UK Article 13.1 authorised claim "Choline contributes to the maintenance of normal liver function" rests on this mechanism. Choline-deficiency-induced hepatic steatosis is well-characterised in animal models and in human total-parenteral-nutrition contexts.
Lipid metabolism — VLDL packaging and homocysteine-betaine axis. Choline contributes to lipid metabolism via two routes: phosphatidylcholine for VLDL packaging (hepatic lipid export) and betaine for homocysteine remethylation. Elevated homocysteine is associated with cardiovascular risk in observational studies. The UK Article 13.1 authorised claim "Choline contributes to normal lipid metabolism" rests on the VLDL mechanism.
Homocysteine metabolism — betaine pathway. Choline → betaine → methionine via BHMT. The UK Article 13.1 authorised claim "Choline contributes to normal homocysteine metabolism" rests on this pathway. Adequate choline contributes alongside folate, vitamin B12, and vitamin B6 to homocysteine regulation — these nutrients act on parallel arms of the same one-carbon methylation cycle.
Acetylcholine synthesis — cognitive axis. Choline acetyltransferase synthesises acetylcholine from choline and acetyl-CoA in cholinergic neurons. Acetylcholine is the principal neurotransmitter at neuromuscular junctions and for autonomic parasympathetic signalling, and is a key neurotransmitter in memory and attention pathways (including the basal forebrain projections to the cortex that are affected in Alzheimer's disease). Cholinergic signalling is the basis of cholinesterase inhibitor pharmacology (donepezil, rivastigmine, galantamine) used in Alzheimer's disease.
Foetal neural-tube and cognitive development. Maternal choline status during pregnancy is associated with foetal hippocampal development, attention markers in the infant and child, and cognitive-test performance through age 7 (Caudill 2018 RCT in pregnant women showing higher attention scores at age 7 in children of women supplemented with 930 mg/day vs 480 mg/day; Boeke 2013 cohort association). Choline is closely related to folate in the one-carbon pool — folate spares choline and choline spares folate in cell-biology and animal-model contexts. UK pregnancy supplement guidance is increasingly including choline alongside the established folate / vitamin D / iodine bundle, particularly for women carrying PEMT polymorphisms with reduced endogenous synthesis capacity.
Trimethylaminuria (TMAU) — the fishy-odour metabolic concern. Gut bacteria metabolise unabsorbed dietary choline and L-carnitine to trimethylamine (TMA). The liver enzyme flavin-containing monooxygenase 3 (FMO3) oxidises TMA to the odourless trimethylamine-N-oxide (TMAO). In trimethylaminuria — a rare genetic disorder of FMO3 — TMAO production is impaired and TMA accumulates, producing a fishy body odour. High choline intake in TMAU patients exacerbates the odour. Some non-TMAU adults experience mild fishy odour from very high choline intakes (typically choline bitartrate ≥3 g/day). Dose reduction or change to phosphatidylcholine form (which is more efficiently absorbed in the small intestine before reaching colonic bacteria) typically resolves.
TMAO and cardiovascular controversy. Hazen 2011 (Nature) and 2013 (NEJM) reported that gut-microbiome-generated TMAO from dietary choline and L-carnitine is associated with adverse cardiovascular events in observational cohorts, with mechanism evidence that TMAO impairs reverse cholesterol transport and promotes atherosclerosis in animal models. The work has been controversial — subsequent analyses have questioned the causal contribution of dietary choline relative to other dietary patterns, and some interventional trials have not replicated the pathway in humans. The conservative position is that meeting EFSA AI (400-520 mg/day) from food and supplements is appropriate; gross overconsumption (>3 g/day chronically) is not advisable both for the TMAU concern and for the unsettled TMAO question.
Common myths
Myth""Eggs cause heart attacks because of choline.""
RealitySubstantial overstatement. The TMAO controversy is real but causally unsettled, and the egg-and-cardiovascular-disease literature broadly does NOT support eggs as a CV-risk food for the general population (Drouin-Chartier 2020 BMJ meta-analysis pooling >170,000 participants found no association between moderate egg consumption and CV disease). Eggs remain on the UK NHS Eatwell Guide as a healthy protein source. Meeting choline AI from dietary eggs is not the same as gross overconsumption from supplements. [1]
Myth""Choline is just a B vitamin — they're all the same.""
RealityCholine was historically grouped with B vitamins ("vitamin B4") in some older classifications but is no longer treated as a B vitamin in modern nomenclature. It is a quaternary amine, not a vitamin in the classical sense (humans can synthesise some via PEMT). It does feature in the same one-carbon methylation pathway as folate (B9) and vitamin B12 — the biological cooperation is real even though the classification is distinct.
Myth""Alpha-GPC and CDP-choline are dramatically better than regular choline for the brain.""
RealityBoth forms cross the blood-brain barrier more efficiently than choline bitartrate per gram, and both have small early-trial evidence in cognitive endpoints. But the dose used in trials of alpha-GPC and CDP-choline is much smaller than the dose of choline bitartrate that would deliver equivalent elemental choline — meaning the cost-per-mg-of-choline is much higher. For meeting AI for general dietary purposes, choline bitartrate or phosphatidylcholine (lecithin) is more cost-effective. For cognitive-enhancement framings, the trial evidence supporting alpha-GPC and CDP-choline is modest and concentrated in specific clinical populations (mild cognitive impairment, post-stroke).
Myth""More choline is always better for memory.""
RealityTrial evidence does not support a dose-response. EFSA AI (400 mg/day adults) is the reference. High doses (>3 g/day chronically) increase the TMAU and TMAO concerns and produce side effects (fishy odour, sweating, GI upset, hypotension in some users). The "more is better" framing is wrong.
Myth""Choline supplementation is essential for vegans.""
RealityCholine is an essential nutrient for everyone; vegans face a higher risk of low intake because the most concentrated common dietary sources (eggs, beef liver, salmon, chicken) are animal-source. Plant sources (soy, soy lecithin, sunflower lecithin, broccoli, cauliflower, peanuts) can meet AI but require attention. A vegan diet with daily soy products, whole grains, and nuts can meet the 400 mg/day AI; some vegans benefit from a sunflower-lecithin or choline-bitartrate supplement to be safe. The general nutrient-deficiency-risk position for vegans (B12, vitamin D, iodine, omega-3 ALA→DHA conversion, iron, zinc, choline) is well-rehearsed in the UK BDA vegetarian / vegan position paper.
What people say online
Choline discourse on TikTok and Reddit clusters around three distinct narratives: pregnancy supplement-stack content surfacing the choline gap in the NHS bundle (mostly accurate, sometimes overstated); the egg-vs-heart-attack debate driven by the TMAO Nature paper (mechanism real, human translation contested); and nootropic / "natural Adderall" framings of alpha-GPC and citicoline (trial-evidence weak in healthy adults). This section surfaces the discourse without naming individuals.
Trending claims
- TikTok + Reddit r/ScienceBasedParenting (pregnancy supplement-stack content)high visibility
Claim: Choline is the new prenatal you're missing
Reality check: The underlying signal is real — the NHS pregnancy bundle (folic acid + vitamin D + iodine) does NOT yet include choline, and Bahnfleth 2022 (PMID 34962672) is the strongest controlled-trial evidence we have for an offspring-cognition benefit. But the trial was small (n=20) and the absolute effect, while statistically significant, is modest. The right action is to talk to your midwife about your dietary choline intake and consider a pregnancy multivitamin that already includes choline — not high-dose single-active supplementation without input. [7]
- TikTok + plant-based-influencer Reddit contenthigh visibility
Claim: Eggs cause heart attacks because of TMAO
Reality check: The TMAO mechanism (Wang/Hazen 2011, PMID 21475195) is real in mouse models. In humans the egg-and-CVD link is NOT supported by the largest meta-analysis we have (Drouin-Chartier 2020 BMJ, PMID 32132002, n=1.7M, pooled RR 0.98 for one egg per day). Eggs remain on the NHS Eatwell Guide. Meeting choline AI from dietary eggs is not the same as gross overconsumption from a high-dose supplement. [9,10]
- TikTok #nootropics + Reddit r/Nootropics + r/StackAdvicehigh visibility
Claim: Alpha-GPC / citicoline is natural Adderall for focus
Reality check: Trial evidence for alpha-GPC and citicoline is concentrated in specific clinical populations — mild cognitive impairment, post-stroke dementia, Alzheimer's adjunct (Bonvicini 2023 PMID 36678257 meta-analysis pooled SMD 0.56-1.57 for cognitive endpoints, but the authors flag "significant risk of bias in favor of the intervention" and "the general quality of the studies is poor"). UK NICE NG97 (Dementia) does NOT include choline supplementation in any form. For healthy adults seeking a focus boost, the evidence base is much weaker than the marketing suggests. [11]
- Reddit r/covidlonghaulers + general long-Covid contentmedium visibility
Claim: Citicoline reverses post-Covid brain fog
Reality check: No high-quality randomised trial currently supports this claim. The Bonvicini 2023 citicoline meta-analysis (PMID 36678257) covers dementia and post-stroke populations, not post-Covid cognitive symptoms. UK NICE has long-Covid guidance (NG188) but it does not include choline supplementation. Anyone with persistent post-Covid cognitive symptoms should be evaluated via NHS Long Covid pathway rather than self-supplementing. [11]
Where the conversation lives
- TikTok hashtags: #pregnancystack, #pregnancysupplements, #nootropics, #alphaGPC, #citicoline, #cholinepregnancy
- Reddit subs: r/Nootropics, r/StackAdvice, r/ScienceBasedParenting, r/longhaulers, r/Supplements
- Forums: Examine.com (paid evidence comparator), Mom-Brain podcasts, prenatal-nutrition YouTube channels
Questions people are searching
- How much choline do I really need each day?
- I'm pregnant — should I take choline?
- Is alpha-GPC better than regular choline for memory?
- My choline supplement makes me smell fishy — what's wrong?
- Are eggs bad for my heart because of TMAO?
- Can I take citicoline for post-Covid brain fog?
Who drives the discourse: The discourse is driven by four creator classes: prenatal- nutrition / midwife / dietitian creators (most NHS-aligned; surfacing the choline gap in the bundle); nootropic / biohacker creators (alpha-GPC / citicoline as cognitive enhancers — generally over-confident relative to the trial-evidence base); plant-based / wellness creators (the TMAO-driven eggs-and-heart-attack narrative — mechanism real, human-translation contested); and long-Covid recovery creators (off-label uses of citicoline for cognitive symptoms). Verifera editorial does not name individuals.
Social-media trends change quickly. This section is editorial commentary on what people are searching for — not a recommendation.
Common online questions
Synthesised from the questions UK shoppers most often ask online about Choline. Each answer is editorial and links to its evidence in the Sources list below.
How much choline do I really need each day?
EFSA Adequate Intake: 400 mg/day for adults; 480 mg/day in pregnancy; 520 mg/day in lactation; ranging from 160 mg (children 1-3 years) to 400 mg (adolescents). Most UK adults consuming eggs and a normal mixed diet meet this from food. Vegans, dairy-avoiders, and people who do not eat eggs may fall below. [1]
I'm pregnant — should I take choline?
Talk to your midwife. EFSA pregnancy AI is 480 mg/day. UK NHS pregnancy supplement profile (folate / vitamin D / iodine) does not yet include choline routinely; specialist preconception practice increasingly does, particularly for women with low egg / dairy intake. 200-450 mg/day supplemental choline (often as phosphatidylcholine for tolerability) is a reasonable conversation; some next-generation UK pregnancy multivitamins already include choline. [2]
Is alpha-GPC better than regular choline for memory?
For mild cognitive impairment / post-stroke contexts, alpha-GPC has small early-trial evidence at 300-1000 mg/day. For healthy- adult cognitive enhancement, the trial evidence is modest and the cost-per-mg-of-choline is much higher than choline bitartrate or phosphatidylcholine. UK NICE NG97 (Dementia) does not include choline supplementation in any form. For general dietary purposes, choline from eggs and other foods is cost-effective and well-evidenced. [4]
My choline supplement makes me smell fishy — what's wrong?
Some adults experience mild fishy odour from high-dose choline bitartrate (typically ≥3 g/day) because gut bacteria metabolise unabsorbed choline to trimethylamine. Trimethylaminuria (TMAU) is a rare genetic version of this with severe odour at lower doses. Solutions: reduce dose; switch to phosphatidylcholine (lecithin) form which is absorbed in the small intestine before reaching colonic bacteria; talk to GP if odour persists — TMAU diagnosis can be confirmed by urinary trimethylamine testing.
I have NAFLD — should I take choline?
Talk to the GP managing your NAFLD. Choline status modulates VLDL packaging and hepatic lipid export; mechanistic basis for the UK Article 13.1 liver-function authorised claim. UK NICE NG49 NAFLD pathway is weight management and metabolic- syndrome control; choline supplementation can be a dietary adjunct conversation but not a primary treatment. [3]
UK regulatory landscape
UK regulatory tier: Food supplement
Choline supplements sit under the UK Food Supplements (England) Regulations 2003 (and devolved equivalents) plus the retained-EU Nutrition and Health Claims Regulation (NHCR). Three Article 13.1 authorised function claims apply to the nutrient: normal lipid metabolism, normal homocysteine metabolism, and maintenance of normal liver function. Choline is NOT a UK Reference Nutrient Intake (RNI) nutrient at population level — the UK has historically not declared choline essential at the same regulatory tier as folate / vitamin D / iodine, although EFSA's 2016 Adequate Intake (AI) is the de facto reference for label and substantiation purposes. Choline is NOT a novel food under the retained Novel Foods Regulation.
What crosses the tier
| Condition | Crosses to |
|---|---|
| Marketing for diagnosed dementia, Alzheimer's disease, mild cognitive impairment, or post-stroke cognitive recovery | |
| Marketing for diagnosed non-alcoholic fatty liver disease (NAFLD) or any other liver-disease indication | |
| Marketing for cardiovascular-disease prevention | |
| Sustained intake above the US IOM/NASEM tolerable upper intake (3.5 g/day adults) |
Permitted claims
Three UK Article 13.1 authorised claims apply (descriptive summary; verbatim register-text capture in `_shared.yml. gb_nhc_register.choline` is pending follow-up): (1) "Choline contributes to normal lipid metabolism"; (2) "Choline contributes to normal homocysteine metabolism"; (3) "Choline contributes to the maintenance of normal liver function". No memory, focus, or cardiovascular-prevention claim is authorised. Claims may be used where the food contains a significant amount of choline per the Annex of the NHCR (82.5 mg per 100 g / 100 ml or per portion as applicable).
Cross-jurisdiction note
US Institute of Medicine declared choline an essential nutrient in 1998 and set an Adequate Intake (550 mg/day men, 425 mg/day non-pregnant women, 450 mg/day pregnancy, 550 mg/day lactation) — slightly different from EFSA AI in pregnancy (480 mg/day) and lactation (520 mg/day). US FDA Daily Value (DV) for label purposes is 550 mg/day. The UK has historically not adopted choline at the same regulatory tier as the IOM but EFSA AI is the de facto reference.
UK regulatory rules evolve. This summary is editorial — businesses should consult regulatory counsel; consumers should consult their pharmacist or GP.
🔬 Camden’s evidence review
The research Camden reviewed, graded on its strength. This is our own appraisal — it sits beneath the official guidance above, never above it.
Adequate intake / homocysteine metabolism
StrongEvidencestrongEFSA established Adequate Intake values for choline in 2016 (DRV opinion). Adequate choline status alongside folate, vitamin B12, and vitamin B6 is required for normal homocysteine metabolism via the betaine-homocysteine methyltransferase (BHMT) pathway. UK Article 13.1 authorised claim "Choline contributes to normal homocysteine metabolism" rests on this mechanism. [14,15]
Liver function — choline deficiency hepatic steatosis
StrongEvidencestrongCholine-deficiency-induced hepatic steatosis is well-characterised in animal models and in human total-parenteral-nutrition contexts. UK Article 13.1 authorised claim "Choline contributes to the maintenance of normal liver function" rests on this mechanism. Trial evidence in NAFLD specifically is mixed; UK NICE NG49 does not include choline supplementation. [3]
Foetal neurodevelopment and cognitive outcomes in offspring
ModerateEvidencemoderateCaudill 2018 RCT in pregnant women supplemented with 480 mg/day vs 930 mg/day choline reported higher offspring attention scores at age 7 in the higher-dose arm. Boeke 2013 Project Viva cohort association data support the link. Project Viva memory-task data at age 7 also support modest effects. UK NHS pregnancy supplement profile does not currently include choline routinely; specialist preconception practice increasingly does. [2]
Cognitive enhancement in healthy adults — alpha-GPC, CDP-choline
LimitedEvidencelimitedSmall early trials in healthy young adults have reported modest improvements in attention and memory tests with alpha-GPC or CDP-choline at 300-1000 mg/day. Subsequent replication is mixed. UK NICE pathway for cognitive concerns does not include choline supplementation. [4]
Mild cognitive impairment / Alzheimer's adjunct
LimitedEvidencelimitedAlpha-GPC and CDP-choline have been studied as adjuncts to cholinesterase inhibitors in Alzheimer''s disease (notably the ASCOMALVA Italian trial of alpha-GPC + donepezil). UK NICE NG97 (Dementia) does not include choline supplementation. Self-supplementation in diagnosed Alzheimer''s disease is not the appropriate pathway. [4]
Cardiovascular outcomes — TMAO controversy
MixedEvidencemixedHazen 2011 (Nature) and 2013 (NEJM) work linking dietary choline / L-carnitine via gut-microbiome TMA / TMAO to cardiovascular events is observationally supportive but causally contested. Subsequent analyses have questioned the contribution of dietary choline relative to other dietary patterns. UK NICE NG238 does not include or contraindicate choline. [5]
Effect matrix — per-condition evidence
Per-outcome summary of the published trial corpus: dose ranges studied, duration, evidence grade, and direction of effect. Each row is a citable claim.
| Outcome | Population | Dose | Duration | Evidence | Direction | Sources |
|---|---|---|---|---|---|---|
| Offspring neurocognitive development (third-trimester maternal supplementation) | pregnancy | 480–930 mg | 12–14 wk | LimitedEvidencelimited | improvement | PMID 34962672 |
| Bahnfleth 2022 PMID 34962672 — 7-year follow-up of pregnancy-feeding RCT n=20. Children of 930 mg/day group showed superior sustained attention vs 480 mg/day (AI) group. Small n (=20) limits generalisability; biological plausibility from neural-tube + choline-acetylcholine pathway. UK SACN does not specify a pregnancy AI distinct from adult AI; EFSA AI is 480 mg/day for pregnancy. | ||||||
| Offspring visual memory (observational, second-trimester intake) | pregnancy | 250–500 mg | 12–14 wk | LimitedEvidencelimited | improvement | PMID 23425631 |
| Boeke 2013 Project Viva prospective cohort n=895 — top-quartile second- trimester maternal choline intake associated with child WRAML2 visual- memory score 1.4 points higher (95% CI 0.5-2.4) at age 7 (P-trend = 0.003). Observational; cannot prove causation. Folate / B12 / betaine did NOT show similar associations — supports specificity of choline signal. | ||||||
| Cardiovascular event risk (TMAO mechanism) | adults | — | — | LimitedEvidencelimited | mixed | PMID 21475195 |
| Wang/Hazen 2011 PMID 21475195 — foundational TMAO-cardiovascular hypothesis. Mouse models showed mechanism; human cohort n~4,000 showed plasma metabolite prediction of cardiovascular events. Subsequent epidemiology has produced mixed signals — eggs (a major dietary choline source) are NOT consistently associated with cardiovascular disease in large prospective studies. UK NICE lipid pathway (NG238) does not flag dietary choline. | ||||||
Evidence grades follow the editorial convention: strong > moderate > limited > very_limited > insufficient. Direction reports the trial corpus consensus (improvement / no_change / mixed / decrement). Schema cross-emitted at MedicalSubstance.relevantClinicalCondition[].
Clinical literature review
Beneath the UK and EU guidance summarised in the guidance section above, this is the research Camden reviewed. The choline literature splits into four threads: pregnancy supplementation and offspring neurodevelopment (Bahnfleth / Caudill 2022 PMID 34962672 follow-up RCT + Boeke 2013 PMID 23425631 cohort association); the TMAO cardiovascular mechanism (Wang/Hazen 2011 PMID 21475195 Nature paper); the eggs-and-cardiovascular-disease epidemiology that the TMAO mechanism doesn't fully predict (Drouin-Chartier 2020 PMID 32132002 BMJ meta-analysis n=1.7M); and the cognitive-marketing forms (citicoline Bonvicini 2023 PMID 36678257 meta-analysis — positive but high risk of bias). UK Article 13.1 authorised claims for normal lipid, homocysteine, and liver function remain the proper consumer-claim scope. UK NICE NG49 (NAFLD), NG97 (Dementia), and NG238 (Cardiovascular) do NOT include choline supplementation in any pathway.
Key trials
Bahnfleth CL, Strupp BJ, Caudill MA, Canfield RL · 2022 · FASEB J · PMID 34962672
Finding: Pregnant women were randomised to 480 mg/day (~AI) or 930 mg/day choline in the third trimester. At age 7, the 930 mg/day group's children showed superior sustained attention on a signal-detection task (SAT score p=0.02; maintained correct signal detections across 12-min session p=0.02). For the briefest 17 ms signals, the 480 mg/day group's children showed a 22.9% decline in hits across the session vs a 1.5% increase in the 930 mg/day group (p=0.04). Authors note that average US choline intake by pregnant women is ~70% of the AI.
Relevance: The strongest controlled-trial signal we have for third- trimester maternal choline supplementation on offspring cognition. Small n (=20) so generalisation is bounded, but the biological plausibility (animal models + mechanistic data) is consistent.
Boeke CE, Gillman MW, Hughes MD et al. · 2013 · Am J Epidemiol · PMID 23425631
Finding: Mean second-trimester maternal choline intake was 328 ± 63 mg/day (below the EFSA pregnancy AI of 480 mg/day). Top quartile of second-trimester choline intake was associated with a child WRAML2 visual-memory score 1.4 points higher (95% CI 0.5-2.4) than the bottom quartile at age 7 (P-trend = 0.003). Folate, B12, and betaine intake at the same timepoints did NOT show similar associations.
Relevance: Observational support for the maternal-choline / child- cognition link in a UK-comparable epidemiological context. Cannot prove causation but the dose-response and specificity to choline (not other one-carbon nutrients) is consistent with the RCT signal.
Wang Z, Klipfell E, Bennett BJ et al. (Hazen SL) · 2011 · Nature · PMID 21475195
Finding: Three metabolites of dietary phosphatidylcholine — choline, trimethylamine N-oxide (TMAO) and betaine — predicted cardiovascular event risk in an independent clinical cohort. Mouse models showed dietary choline, TMAO, or betaine supplementation upregulated macrophage scavenger receptors linked to atherosclerosis; germ-free mice did not produce TMAO from dietary choline, confirming the gut-microbiome dependency. Suppressing intestinal microflora in atherosclerosis-prone mice inhibited dietary-choline-enhanced atherosclerosis.
Relevance: The foundational mechanistic paper for the TMAO- cardiovascular controversy. Triggered a wave of subsequent epidemiology (some supportive, some null) that has NOT been fully resolved in humans. UK NICE NG238 has not adopted dietary choline as a cardiovascular risk factor.
Systematic reviews
- pmid:32132002
Drouin-Chartier 2020 BMJ updated meta-analysis n=1,720,108 across 33 risk estimates: an increase of one egg per day was NOT associated with cardiovascular disease risk (pooled RR 0.98, 95% CI 0.93-1.03). Results were similar for coronary heart disease (RR 0.96) and stroke (RR 0.99). Among Asian cohorts, a modest inverse association was observed (RR 0.92). Conclusion: moderate egg consumption (up to one egg per day) is not associated with cardiovascular disease risk overall.
- pmid:36678257
Bonvicini 2023 Nutrients systematic review + meta-analysis of citicoline for cognitive performance: 7 studies in patients with mild cognitive impairment, Alzheimer's disease, or post-stroke dementia; pooled SMD 0.56-1.57 favouring citicoline across sensitivity analyses. Authors note "the general quality of the studies, however, is poor with significant risk of bias in favor of the intervention" — the positive signal is real but the evidence base is not strong.
Evidence quality summary
Pregnancy maternal-choline / offspring-cognition signal — MODERATE certainty (one small RCT with 7-year follow-up replication-supportive of an underlying biology, plus a separate cohort association in Project Viva). UK Article 13.1 authorised claims for lipid + homocysteine + liver function — well-anchored in nutritional biochemistry (HIGH mechanism certainty). TMAO cardiovascular mechanism — well-characterised in mouse models; HIGH in animals, DEBATED in humans. Citicoline / alpha-GPC for cognitive enhancement in healthy adults — LIMITED certainty (Bonvicini 2023 PMID 36678257 meta-analysis positive but high RoB). Dietary egg consumption and CV disease — HIGH certainty for no overall association (Drouin-Chartier 2020 BMJ n=1.7M).
Known gaps
- Replication of Bahnfleth/Caudill third-trimester choline RCT at larger n is the most important missing study for UK pregnancy policy.
- Long-term outcomes (academic performance, mental-health markers) of children whose mothers were supplemented in the Caudill RCT remain to be measured.
- Head-to-head trials of phosphatidylcholine vs choline bitartrate vs alpha-GPC vs citicoline at matched elemental dose are limited.
- The TMAO-cardiovascular question in free-living humans (not just mice + observational cohorts) is unresolved — randomised dietary-choline-restriction trials with CV endpoints don't exist.
- PEMT and MTHFR polymorphism prevalence in the UK pregnant population, and whether genotype-guided choline supplementation produces better outcomes, is unstudied.
This summarises the published evidence as of the last review date — it is not advice for your specific situation. Talk to your pharmacist or GP.
Safety
Choline is generally well-tolerated at AI-tier intakes (400 mg/day adults, 480-520 mg/day pregnancy / lactation). The realistic considerations are GI side effects at high doses (>3 g/day), the fishy-odour TMAU signal, the unsettled TMAO cardiovascular controversy, and pregnancy supplementation requiring midwife / specialist input.
Talk to your pharmacist or GP first if you:
- You have diagnosed trimethylaminuria (TMAU) — choline supplementation is contraindicated.
- You have hereditary FMO3 polymorphism or family history of unusual body odour — consider GP review for TMAU diagnosis before high-dose choline.
- You are pregnant or breastfeeding — talk to midwife about adding choline alongside folate / vitamin D / iodine bundle.
- You take cholinesterase inhibitor medication (donepezil, rivastigmine, galantamine) — disclose use to neurology / memory clinic.
- You take prescribed antidepressants or anti-anxiety medication — choline acts on cholinergic neurotransmission; theoretical interaction; modest at supplement doses.
- You have a history of cardiovascular disease — meet AI from food rather than gross overconsumption from supplements.
- You are giving any supplement to a child — talk to GP / pharmacist.
Common side effects: Generally well-tolerated at AI-tier doses. Higher doses (>1 g/day): GI upset (nausea, vomiting), sweating, mild fishy odour. Hypotension at very high doses.
Pregnancy and breastfeeding
EFSA Adequate Intake in pregnancy is 480 mg/day, above the adult AI of 400 mg/day. The current UK NHS pregnancy supplement bundle (folic acid + vitamin D + iodine) does NOT include choline routinely. The Bahnfleth 2022 7-year follow-up of the Caudill choline RCT (PMID 34962672) reported better sustained-attention scores at age 7 in children whose mothers consumed 930 mg/day vs 480 mg/day in the third trimester — a small (n=20) but biologically plausible signal, consistent with the Boeke 2013 Project Viva cohort association (PMID 23425631). Talk to your midwife or GP before adding a choline supplement, particularly if you don't eat eggs. If you carry a PEMT polymorphism with reduced endogenous synthesis, the conversation matters more.
EFSA Adequate Intake in lactation is 520 mg/day. Choline is concentrated in breast milk; sustained low maternal intake during prolonged breastfeeding can produce inadequate infant choline. UK NHS does not currently include choline in routine breastfeeding supplement guidance — talk to your midwife or health visitor if your dietary intake is low (no eggs, low dairy, low fish, predominantly plant-based).
Talk to your GP, midwife, or pharmacist before starting any supplement during pregnancy or breastfeeding.
More clinical detail (for clinicians and informed readers)
Contraindications
- Diagnosed trimethylaminuria (TMAU).
- Hypersensitivity to choline or supplement constituents.
- Concurrent high-dose alpha-GPC / CDP-choline use without specialist input in cognitive-impairment or Parkinson's contexts.
Drug interactions
Cholinesterase inhibitors (donepezil, rivastigmine, galantamine) · medium
Effect: Choline supplementation provides extra substrate for acetylcholine synthesis; cholinesterase inhibitors slow the breakdown of acetylcholine in the brain. The combination is pharmacodynamically additive on cholinergic signalling and may amplify both the intended cognitive effect and the cholinergic side effects (nausea, diarrhoea, slow heart rate, vivid dreams).
Mechanism: Both interventions raise acetylcholine availability — one by providing more substrate, the other by inhibiting the enzyme that clears acetylcholine. Most clinically relevant with the cognitive-marketing forms (alpha-GPC, citicoline) at higher doses.
Action: Tell the neurology or memory clinic looking after your diagnosis if you're considering high-dose choline, alpha-GPC, or citicoline. The prescriber will balance any expected cognitive benefit against the risk of side-effect amplification.
Source: BNF cholinesterase inhibitors + UK NICE NG97 Dementia
Anticholinergic medication (oxybutynin, tolterodine, hyoscine, certain tricyclic antidepressants) · low
Effect: Pharmacodynamic opposition — anticholinergics block muscarinic acetylcholine receptors; choline supplementation may modestly increase acetylcholine availability. Clinical relevance at AI-tier choline doses is small.
Mechanism: Opposing pharmacodynamic effects on cholinergic signalling. Most relevant with the cognitive-marketing forms at higher doses (alpha-GPC ≥600 mg/day, citicoline ≥1 g/day).
Action: Mention any choline-containing supplement to your prescriber or pharmacist if you take an anticholinergic medicine for an active indication (overactive bladder, motion sickness, depression).
Source: BNF antimuscarinic + anticholinergic drugs
Methotrexate — folate-pathway adjacency; modest interaction at choline supplement doses.
Anti-Parkinson medication (dopaminergic agents, COMT inhibitors) — modest theoretical interaction.
Tell your prescriber if you take any of these combinations. This is not personalised advice.
This is not an exhaustive list. Always tell your prescriber and pharmacist about every supplement you take.
Common side effects
- Generally well-tolerated at standard supplement doses (100-450 mg/day elemental).
- Mild GI upset (nausea, abdominal cramping, soft stools) at higher doses.
- Increased sweating at higher doses.
Rare side effects
- Mild fishy body odour (gut-microbiome-derived TMA in non-TMAU users; severe in TMAU).
- Hypotension at very high doses (>3 g/day chronically).
- Allergic reactions (rare).
- Increased depression / mood symptoms — reported in some early choline-deficiency-correction studies; mechanism uncertain.
How to take it
- Typical supplemental range
- General dietary supplementation: 100-300 mg/day choline as choline bitartrate or phosphatidylcholine. Pregnancy supplementation: 200-450 mg/day, often as phosphatidylcholine. Cognitive-marketed alpha-GPC: 300-1000 mg/day. CDP-choline: 250-1000 mg/day.
- Timing
- Daily — split-dose 2× daily for higher-dose protocols. Take with food for tolerability.
How to spot quality
Look for
- Choline form declared (bitartrate, citrate, phosphatidylcholine, alpha-GPC, CDP-choline / citicoline).
- Elemental choline per serving stated — not just "choline 500 mg" which could be 200 mg elemental from bitartrate or 65 mg from phosphatidylcholine.
- For phosphatidylcholine / lecithin: source declared (soy or sunflower; sunflower is preferred for soy-allergic users).
- For alpha-GPC and CDP-choline: research-grade purity declared.
- GMP-certified manufacture.
- For pregnancy multivitamins: 100-450 mg/day choline contribution alongside the 400 µg folate, 10 µg vitamin D, 150 µg iodine bundle.
Red flags
- Total choline-salt weight on the front of the label without elemental choline per serving.
- No form declaration ("choline" without species).
- Marketing alpha-GPC or CDP-choline as "smart drug" or "natural Adderall" — outside trial-evidence boundaries.
- Marketing for diagnosed dementia or Alzheimer's disease without specialist input — outside UK NICE pathway.
- Marketing in a TMAU context — choline supplementation is contraindicated in trimethylaminuria.
- Cardiovascular-prevention positioning at gross-overconsumption doses (>3 g/day elemental choline).
Commonly combined with
Other ingredients that share a biological pathway, cofactor relationship, or evidence-backed protocol with this one. Mechanisms below cite primary physiology — not folk pairing. Doses are literature ranges, not recommendations. Talk to your pharmacist or GP before changing your stack, especially if you take prescription medication.
Methyl Folate (5-Methyltetrahydrofolate)
Limited evidenceThe canonical one-carbon methylation pairing — folate and choline cooperate on homocysteine remethylation via parallel methyl-donor pathways.
Folate (via 5-methyl-THF and methionine synthase) and choline (via betaine and BHMT) provide methyl groups to homocysteine, regenerating methionine. The two pathways are parallel and partially compensatory: low folate increases reliance on the betaine pathway, and low choline increases reliance on the folate pathway. Homocysteine elevation can occur when both are insufficient simultaneously.
In pregnancy, both nutrients are critical — folate for neural tube closure (weeks 4-6), choline for foetal hippocampal development and cognitive markers in the offspring. UK NHS pregnancy supplement guidance requires 400 µg/day folate (preconception through first trimester); choline is increasingly being added to specialist preconception practice at 200-450 mg/day.
The combination is mechanism-additive on the homocysteine axis and complementary on the foetal neurodevelopment axis. UK Article 13.1 authorised homocysteine-metabolism claims for both.
Evidence: One-carbon methylation pathway is well-characterised. UK NHS pregnancy folate evidence is strong. Choline in pregnancy (Caudill 2018 RCT) is moderate.
Doses studied: 400 µg/day folate (or methyl-folate for MTHFR-variant individuals) + 200-450 mg/day choline (often as phosphatidylcholine) in preconception and pregnancy bundles.
Vitamin B12
Moderate evidenceOne-carbon methylation cluster — folate, B12, B6, and choline form the core homocysteine-regulation set.
Methionine synthase (the principal homocysteine-remethylation enzyme) requires vitamin B12 as a cofactor. Choline via betaine provides an alternative methyl-donor route via BHMT. The two routes are biochemically parallel and clinically complementary — sustained low B12 reduces flux through methionine synthase and increases reliance on the BHMT pathway, requiring adequate choline.
Both have UK Article 13.1 authorised claims for homocysteine metabolism. The combination appears in many UK general multivitamins and in pregnancy / preconception bundles.
Evidence: Mechanism well-established. UK Article 13.1 authorised homocysteine claim for B12 (gb-nhc:vitamin_b12). [6]
Doses studied: 2.5-1000 µg/day vitamin B12 (methylcobalamin or cyanocobalamin) + 100-450 mg/day choline.
Inositol (Myo-Inositol, D-Chiro-Inositol)
Limited evidencePreconception cluster — both are second-messenger / membrane-phospholipid actives with complementary roles in foetal neural development.
Choline → phosphatidylcholine → membrane structure + acetylcholine signalling. Inositol → phosphatidylinositol → IP3 second messenger + membrane structure. Both are critical for foetal neural development; both are non-essential nutrients with EFSA AI / non-RNI status.
The combination is mechanism-supportive (different aspects of neural-membrane phospholipid composition) and appears in next-generation UK preconception bundles. Trial evidence on the combination specifically is limited; each component has its own trial body.
Evidence: Mechanism complementary on neural-membrane phospholipid axis. Combination trials limited.
Doses studied: 200-450 mg/day choline + 2-4 g/day myo-inositol (often as 40:1 MI:DCI ratio for women with PCOS).
Lion's Mane
Limited evidenceCognitive cluster pairing — choline (acetylcholine substrate) plus Lion's Mane (NGF-promoting hericenones / erinacines) for complementary cognitive-mechanism framings.
Acetylcholine is the principal cholinergic neurotransmitter for memory and attention pathways. Choline supplementation increases acetylcholine substrate availability. Lion's Mane (Hericium erinaceus) hericenones and erinacines have cell-biology evidence for stimulating nerve growth factor (NGF) synthesis. The two mechanisms are complementary on the cognitive axis without overlapping.
Trial evidence on the combination specifically is limited; each component has modest individual trial evidence in mild cognitive impairment contexts. UK NICE NG97 (Dementia) does not include either supplement.
Evidence: Mechanism complementary across acetylcholine and NGF axes. Combination trials small. Camden's lions-mane is in NB-503.
Doses studied: 200-600 mg/day choline (often alpha-GPC or CDP-choline for the cognitive axis) + 500-1000 mg/day Lion's Mane fruiting-body extract.
Found in Camden: Mycofera™ Lions Mane Extract with Acerola & Black Pepper 120 Capsules
Trimethylglycine (TMG / Betaine anhydrous)
Limited evidenceDirect downstream metabolite — choline is oxidised in the liver to betaine (TMG), the methyl donor for the BHMT homocysteine-remethylation pathway.
Choline → choline dehydrogenase / betaine aldehyde dehydrogenase → betaine (trimethylglycine, TMG). Betaine donates a methyl group to homocysteine via betaine-homocysteine methyltransferase (BHMT), regenerating methionine. The pathway is the direct metabolic relationship — supplementing choline upstream and supplementing TMG downstream both feed the same homocysteine-remethylation route.
TMG supplementation bypasses the choline-oxidation step and is an option for individuals who do not absorb / metabolise choline efficiently. Camden's tmg entry covers TMG specifically.
Evidence: Direct metabolic relationship. TMG / betaine has its own authorised UK Article 13.1 homocysteine claim.
Doses studied: Either choline 200-450 mg/day OR TMG 500-1500 mg/day — not necessarily both, since they feed the same pathway.
Verifera™ editorial perspective
Why it matters. Choline is one of the highest-stakes pregnancy-nutrition clusters in consumer supplement research — a real controlled-trial signal in third-trimester maternal supplementation (Bahnfleth 2022 PMID 34962672), a real UK Article 13.1 authorised claim set (lipid + homocysteine + liver function), and a contested cardiovascular controversy (Wang/Hazen 2011 TMAO mechanism, PMID 21475195; Drouin-Chartier 2020 BMJ eggs-and-CV null meta-analysis, PMID 32132002). The Verifera editorial position is that this entry needs to be honest about the food-first NHS framing (most UK adults who eat eggs meet the AI from diet), the gap in the NHS pregnancy bundle (folic acid + vitamin D + iodine — no choline yet), and the much weaker trial evidence for the cognitive-marketing forms (alpha-GPC, citicoline) in healthy adults.
Where Camden lands. Camden Medicals does NOT currently retail a single-active choline SKU. For most adults the food-first answer (eggs, salmon, chicken, soy lecithin) is appropriate. For pregnancy or for adults on egg-free diets, the right tier is a multivitamin that includes choline alongside the NHS bundle — Camden's product range may add this contribution at a future Phase 2 stage but does not today. The cognitive- marketing alpha-GPC and citicoline forms are deliberately outside Camden's range — the trial-evidence base is concentrated in specific clinical populations (mild cognitive impairment, post-stroke), not in healthy adults seeking a focus boost.
If you want to explore further. Audit your diet first. A daily egg gives you ~150 mg choline; salmon, chicken, milk, broccoli, and soy lecithin add to that. Most UK adults who eat eggs already meet the AI from food. If you don't eat eggs (vegan, allergic, or food- avoidant) talk to your GP or a registered nutritionist about whether a phosphatidylcholine (sunflower or soy lecithin) supplement is worth adding. For pregnancy: talk to your midwife about your dietary choline intake before adding any supplement; pregnancy multivitamins increasingly include 100-200 mg choline as part of the bundle. For diagnosed trimethylaminuria (TMAU): choline supplementation is contraindicated; specialist input via your GP and the rare- disease service.
How this entry was researched
Authoritative sources consulted:
- NHS Eatwell Guide + Pregnancy: vitamins, supplements and nutrition pages
- NICE NG49 (NAFLD) + NG97 (Dementia) + NG238 (Cardiovascular) + NG188 (Long Covid) pathways
- EFSA 2016 DRV opinion for choline (Adequate Intake)
- US Institute of Medicine 1998 essential-nutrient declaration for choline
- GB Nutrition and Health Claims (NHC) Register — three Article 13.1 authorised claims (lipid, homocysteine, liver function)
- BNF (cholinesterase inhibitors, anticholinergic drugs)
- UK BDA position paper on vegetarian / vegan diets (B12, iron, iodine, choline)
- PubMed (via E-utilities MCP, 2026-05-12)
PubMed search terms:
Caudill choline supplementation pregnancy attention infantBoeke project viva choline pregnancy memory child cognitionDrouin-Chartier eggs cardiovascular disease meta-analysis 2020Wang Hazen TMAO gut flora cardiovascular risk Nature 2011citicoline mild cognitive impairment systematic review
Literature search date: 2026-05-12
Sources listed are those consulted by the Verifera™ editorial team. Readers should verify against current authoritative sources.